MMED · trading date Oct 12, 2026 · previous close $19.73 · source: Alpaca (IEX feed, not consolidated full-market data).
Key Financials
Revenue
$3.10B
Net income
-$333.00M
Total assets
$4.63B
Total liabilities
$1.02B
Stockholders' equity
$3.61B
Cash & equivalents
$298.00M
Operating income
-$190.00M
Operating cash flow
-$197.00M
Capital expenditures
$223.00M
Fiscal year 2026, via 10-K filed 2026-06-29.
A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
-6.1%
Net margin
-10.7%
Free cash flow
-$420.00M
Free cash flow margin
-13.5%
Liabilities / assets
22.0%
Equity / assets
78.0%
CapEx / revenue
7.2%
Operating cash flow / net income
0.59×
Derived from the fiscal year 2026 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Northridge, CA 91325
18000 DEVONSHIRE ST.
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:20 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.